Meetings and Conferences · Tagungen und Kongresse
Koji Kawakami(Kyoto University), Wen Yun, Michael Untch(Helios Kliniken), Shota Hamada(National Institute for Health and Care Research), Brigitte Rack(LMU Klinikum), Frederik Wenz(University Medical Center Freiburg), Peter Dall, Ana Catarina Pinto, Ayotunde James Fasunla, Christian Jackisch(Goethe University Frankfurt), Elmar Stickeler(Universitätsklinikum Aachen), Andreas Schneeweiss, Sabina Berktold, Nadia Harbeck(Breast Center), Ingo Bauerfeind, Rachel Schiff(Baylor College of Medicine), Petra Klose(University of Duisburg-Essen), Holm Eggemann, Petra Wolf, Meghana V. Trivedi(University of Houston), Atanas Ignatov(Otto-von-Guericke-Universität Magdeburg), Shira Peleg Hasson, Mario Giuliano(Regione Campania), Tamar Rubinek(Tel Aviv University), Peter Hass, Hiroshi Ishiguro, Silke Steinbach(Krankenhaus vom Roten Kreuz), Petra Voiß, Evandro de Azambuja(Université Libre de Bruxelles), Anna Paul, Ido Wolf(Tel Aviv University), Martine Piccart(Université Libre de Bruxelles), Christina Böhner, Masakazu Toi(Mukogawa Women's University), Jian Li, Silke Lange(Witten/Herdecke University), Bernd Gerber(Universitäts Frauenklinik), Roland Stabenow(Fondazione IRCCS Istituto Nazionale dei Tumori), Sherko Kümmel(Kliniken Essen-Mitte), Florian Schütz(Heidelberg University), Gustav Dobos(University of Duisburg-Essen), Walter Hundt, Friedrich W. Röhl, Serban-Dan Costa, Cornelia Liedtke, Gϋnter von Minckwitz(German Breast group), L Ryvo, Shiro Hinotsu(Sapporo Medical University), Caterina Fontanella
Cited by 0
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k